1 Introduction to emerging infectious diseases; stemming the tide

Biomedical Research Reports

Volumn 1, Issue C, 1998, Pages 1-22

  Krause, Richard M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957030096     PISSN: 18745326     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5326(07)80025-1     Document Type: Article

References (40)

1. Anderson R.M. Analytical Theory of Epidemics. In: Krause R.M. (Ed). Emerging Infections (1997), Academic Press, New York 23-49 (this volume)
2. Anderson R.M., Donnelly C.A., Ferguson N.M., Woolhouse M.E.J., Watt C.J., Udy H.J., MaWhinney S., Dunstan S.P., Southwood T.R.E., Wilesmith J.W., Ryan J.B.M., Hoinville L.J., Hillerton J.E., Austin A.R., and Wells G.A.H. Transmission dynamics and epidemiology of BSE in British cattle. Nature (London) 382 (1996) 779-788
3. Avery O.T., Chickering H.T., Cole R., and Dochez A.R. Acute lobar pneumonia; prevention and serum treatment. Monograph 7 (1917), Rockefeller Institute for Medical Research, New York 1-109
4. Beasley R.P., Hwang L.-Y., Stevens C.E., Lin C.-C., Hsieh F.-J., Wang K.-Y., Sun T.-S., and Szmuness W. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of hepatitis B virus carrier state: Final report of randomized double-blind, placebocontrolled trial. Hepatology 3 (1983) 135-141
5. Black F.L. Why did they die?. Science 258 (1993) 1739-1740
6. Bushnell O.A. The Gifts of Civilization: Germs and Genocide in Hawaii (1993), Univ. of Hawaii Press, Honolulu 188
7. Casadevall A. Crisis in infectious disease: Time for a new paradigm?. Clin. In fect: Dis. 23 (1996) 790-794
8. Caverly C.S. Preliminary report of an epidemic of paralytic disease occurring in Vermont, in the summer of 1894. Yale Med. J. 1 (1894) 1
9. Cook J. The method taken for preserving the health of the crew of His Majesty's Ship The Resolution during her late voyage round the world. Philos. Trans. R. Soc. 66 (1776) 402-406
10. Densen P., Clark R.A., and Nauseef W.M. Granulolytic phagocytosis. In: Mandell G.L., Bennet J.E., and Dolm R. (Eds). Principles and Practices of Infectious Diseases (1995), Churchill Livingston, New York 78-101
11. Ewald P.W. Guarding against the most dangerous emerging pathogens: Insights from Evolutionary Biology. Emerging Infectious Diseases 2 (1996) 245-257
12. Eyler J.M. Victorian Social Medicine, the Ideas and Methods of William Farr (1979), Johns Hopkins Univ. Press, Baltimore
13. Goldschneider I., Lepow M.L., and Gotschlich E.C. Immunogenicity of the group A and group C meningococcal polysaccharides in children. J. Infect. Dis. 125 (1971) 509-519
14. Jones T.D., and Bland E.F. The natural history of rheumatic fever. In: Thomas L. (Ed). Rheumatic Fever (1952), Univ. of Minnesota Press, London 5-16
15. Kilbourne E. The emergence of "emerging diseases": A lesson in holistic epidemiology. Mount Sinai J. Med. 63 (1996) 159-166
16. Krause R.M. The Restless Tide: The Persistent Challenge of the Microbial World (1981), The National Foundation for Infectious Diseases, Washington, D.C.
17. Krause R.M. The origin of plagues: Old and new. Science 257 (1992) 1073-1078
18. Lederberg J., Shope R., and Oaks S.C. Report: Institute of Medicine. Emerging Infections: Microbial Threats to Health in the United States (1992), National Academy Press, Washington, D.C.
19. Loefler I.J. Microbes, chemotherapy, evolution, and folly. Lancet 348 9043 (1996) 1703-1704
20. Louria D.B. Emerging and re-emerging infections: The societal variables. International Journal of Infectious Diseases 1 (1996) 59-62
21. Lutz W. The Future of World Population. Population Bulletin No. 49 (1994), Population Reference Bureau, Inc., Washington, D.C.
22. McNeil W. Plagues and Peoples (1976), Doubleday, New York
23. Mahmoud A.F. New intestinal parasitic protozoa. In: Krause R.M. (Ed). Emerging Infections (1997), Academic Press, New York 431-446 (this volume)
24. Mogabgab W.J., Holmes B.J., and Pollock B. Antigenic relationships of common rhinovirus types from disabling upper respiratory illnesses. International Symposium on Immunity to Infections of the Respiratory System in Man and Animals, London 1974. Dev. Biol. Stand. 28 (1975) 400-411
25. Morse S.S. Emerging Viruses (1993), Oxford Univ. Press, New York New York
26. Morse S.S. Factors in the emergence of infectious disease. Emerging Infectious Diseases 1 (1995) 7-15
27. Mortimer S.A. Pertussis vaccine. In: Plotkin S.A., and Moritmer E.A. (Eds). Vaccines (1994), Saunders, Philadelphia 91-135
28. Musser J.M., and Krause R.M. The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome. In: Krause R.M. (Ed). Emerging Infections (1997), Academic Press, New York 185-218 (this volume)
29. National Institute of Allergy and Infectious Diseases. Report of the task force on microbiology and infectious diseases (1992), National Institutes of Health Publication No. 92-3320, Bethesda, Maryland
30. Neustadt R.E., and Fineberg H.V. The Swine Flu Affair: Decision-making on a Slippery Disease (1978), U.S. Department of Health, Education and Welfare, Washington, D.C.
31. Pappenheimer Jr. A.M., and Murphy N.R. Studies on the molecular epidemiology of diptheria. Lancet 2 8356 (1983) 923-926
32. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., and Ho D.D. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271 5255 (1996) 1582-1586
33. Plotkin B.J., and Kimball A.M. Designing an international policy and legal framework for the control of emerging infectious diseases: First steps. Emerging Infectious Diseases 3 1 (1997) 1-9
34. Quinn T.C., and Fauci A.S. The AIDS epidemic: Demographic aspects, population biology, and virus evolution. In: Krause R.M. (Ed). Emerging Infections (1997), Academic Press, New York 327-364 (this volume)
35. Robbins F.C. Polio-Historical. In: Plotkin S.A., and Mortimer E.A. (Eds). Vaccines (1994), Saunders, Philadelphia 137-154
36. Robbins J.B., Schneerson R., and Szu S. Perspective hypothesis: Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. In f. Dis. 171 (1995) 1387-1398
37. Schneerson R., Barrera O., Sutton A., and Robbins J.B. Preparation, characterization, and immunogenicity of H. influenzae-type b polysaccharide-protein conjugates. J. Exp. Med. 152 (1980) 361-376
38. Shilts R. And the Band Played On: Politics, People, and the AIDS Epidemic (1987), St. Martin's Press, New York
39. Tenner-Racz K., Racz P., Dietrich M., and Kern P. Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet 1 8420 (1985) 105-106
40. Webster R.G. Influenza: An emerging microbial pathogen. In: Krause R.M. (Ed). Emerging Infections (1997), Academic Press, New York 275-300 (this volume)